Skip to content

LifeScan Belgium

Active
Private limited companyfounded 20188 yrs activeNijverheidsstraat 13, 2260 Westerlo, BelgiumKBO/BCE: BE 0696.820.779
Summary

LifeScan Belgium has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.89M and a net result of €210k. Equity is growing by ~10% per year across the filed fiscal years. Its solvency ranks better than 45% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2024
52 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability47▼-23
Solvency59▲+10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €95k at 30 days only on tighter terms
Liquidity ample (current ratio 1.6 against 1.37 in 2023; short-term debt: 61.7% and cash: 0% of total assets), but 66.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises risk
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
33.8%
Return on assets
3.8%
Age of the figures
21 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 8 years 0 10 y
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2026, 335 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 7 filings
Deviation from the deadline
2025
not confirmed
2024
335 d late
2023
9 d early
2022
26 d early
2021
39 d early
2020
17 d early
2019
25 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€1.89M▲ 12.5%
2023 · €1.68M
2018: €678k 2019: €1.20M 2020: €1.31M 2021: €1.57M 2022: €1.60M 2023: €1.68M
2018 → 2024
Total assets
€5.60M▼ 21.7%
2023 · €7.16M
2018: €6.76M 2019: €5.75M 2020: €3.63M 2021: €7.48M 2022: €6.19M 2023: €7.16M
2018 → 2024
Net result
€210k▲ 149%
2023 · €84k
2018: €65k 2019: €526k 2020: €106k 2021: €259k 2022: €32k 2023: €84k
2018 → 2024
Working capital
€2.06M▲ 7.0%
2023 · €1.93M
2018: €-2.49M 2019: €-1.25M 2020: €-674k 2021: €513k 2022: €1.34M 2023: €1.93M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€1.31M-€1.57M▲ 19.8%€1.60M▲ 2.0%€1.68M▲ 5.3%€1.89M▲ 12.5%
Operating result€263k-€541k▲ 106%€175k▼ 67.6%€299k▲ 70.7%€366k▲ 22.5%
Net result€106k-€259k▲ 145%€32k▼ 87.6%€84k▲ 163%€210k▲ 149%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2020: €263k€263kNet result 2020: €106k€106kOperating result 2021: €541k€541kNet result 2021: €259k€259kOperating result 2022: €175k€175kNet result 2022: €32k€32kOperating result 2023: €299k€299kNet result 2023: €84k€84kOperating result 2024: €366k€366kNet result 2024: €210k€210k20202021202220232024€0€100k€200k€300k€400kOperating result 2022: €175k€175kNet result 2022: €32k€32kOperating result 2023: €299k€299kNet result 2023: €84k€84kOperating result 2024: €366k€366kNet result 2024: €210k€210k202220232024
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 23% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €5.60M
Fixed assets €83k ▲ 26.6%
Current assets €5.52M ▼ 22.2%
Equity and liabilities €5.60M
Equity €1.89M ▲ 12.5%
Debt €3.71M ▼ 32.3%
Debt's share of the balance-sheet total falls from 76.5% to 66.2%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
Current ratio
1.60
2023 · 1.37
Debt to equity
1.96
2023 · 3.25
ROE
11.1%
2023 · 5.0%
ROA
3.8%
2023 · 1.2%
Debt ≤ 1 year
€3.45M
2023 · €5.16M
Income taxes
€57k
2023 · €100k
Staff costs
€3.19M
2023 · €3.55M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 40 lines
Balance sheet Code20232024
Assets
Total assets20/58€7.16M€5.60M
Fixed assets21/28€66k€83k
Financial fixed assets28€66k€83k
Current assets29/58€7.09M€5.52M
Amounts receivable within one year40/41€7.09M€5.52M
Trade receivables40€591k€980k
Other amounts receivable41€6.50M€4.54M
Cash at bank and in hand54/58-€24
Equity and liabilities
Total equity and liabilities10/49€7.16M€5.60M
Equity10/15€1.68M€1.89M
Contributions10/11€612k€612k=
Reserves13€3k€3k=
Distributable reserves133€3k€3k=
Profit (loss) carried forward14€1.07M€1.28M
Amounts payable17/49€5.47M€3.71M
Amounts payable after more than one year17€24k-
Other amounts payable178/9€24k-
Amounts payable within one year42/48€5.16M€3.45M
Trade debts44€61k€90k
Suppliers440/4€61k€90k
Taxes, remuneration and social security45€1.05M€552k
Taxes450/3€21k€31k
Remuneration and social security454/9€1.03M€521k
Other amounts payable47/48€4.05M€2.81M
Accrued charges and deferred income492/3€288k€253k
Income statement Code20232024
Remuneration, social security and pensions62€3.55M€3.19M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€569k-
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€90€24k
Other operating charges640/8€109€118
Gross operating margin9900€4.42M€3.58M
Operating profit (loss)9901€299k€366k
Financial charges65/66B€115k€100k
Recurring financial charges65€115k€100k
Profit (loss) for the period before taxes9903€184k€267k
Income taxes67/77€100k€57k
Profit (loss) for the period9904€84k€210k
Profit (loss) for the period to be appropriated9905€84k€210k
Appropriation of the result
Profit (loss) to be appropriated9906€1.07M€1.28M
Profit (loss) brought forward from the previous period14P€984k€1.07M
Social balance
Average headcount (FTE)908719.514.3

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
01-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 335 days late
2024
22-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
05-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Weakest financial yearnet €32k ▼87.6%
Net result drops to €32k, the lowest in the series; recovery starts the following year.
22-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
14-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
25-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 25 days late
2019
31-12
Financial Highest result since 2018net €526k ▲704%
Operating result €956k, net result €526k, both a record.
31-12
Financial Equity above €1MEq €1.20M ▲77.5%
2 profitable years in a row build equity to €1.20M.
18-11
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 110 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
20 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Westerlo · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Nijverheidsstraat 132260 Westerlo
Ground area
2.4 ha
Building footprint
1,680 m²
Volume, LiDAR
37,410 m³
Parcel 13028B0138/00V000, Flanders · tallest building 30.0 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
LifeScan Belgium
Nijverheidsstraat 13, 2260 WesterloWholesale of pharmaceutical and medical goods
since 20182.276.351.755
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
13028B0138/00V000 Flanders 2.4 ha 1 · 1,680 m² 30.0 m · 8 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,070 companies in sector 47741 we hold annual accounts for 644. 306 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-05-2018
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.